Clinical Trial Update: Diagnostic and Prognostic Biomarkers in SARS-CoV-2 Infections

View source ↗

Summary

Completed clinical trial evaluating diagnostic and prognostic biomarkers in SARS-CoV-2 infections, with relevance to inflammatory bowel disease and COVID-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: IBD - Inflammatory Bowel Disease, COVID - 19 | Status: COMPLETED